Titre : Orphénadrine

Orphénadrine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Sensitivity and Specificity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Orphénadrine : Questions médicales les plus fréquentes", "headline": "Orphénadrine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Orphénadrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-18", "dateModified": "2025-03-15", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Orphénadrine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés benzhydryliques", "url": "https://questionsmedicales.fr/mesh/D001559", "about": { "@type": "MedicalCondition", "name": "Composés benzhydryliques", "code": { "@type": "MedicalCode", "code": "D001559", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.115" } } }, "about": { "@type": "MedicalCondition", "name": "Orphénadrine", "alternateName": "Orphenadrine", "code": { "@type": "MedicalCode", "code": "D009966", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "L S Sorokina", "url": "https://questionsmedicales.fr/author/L%20S%20Sorokina", "affiliation": { "@type": "Organization", "name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia." } }, { "@type": "Person", "name": "D V Ryabova", "url": "https://questionsmedicales.fr/author/D%20V%20Ryabova", "affiliation": { "@type": "Organization", "name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia." } }, { "@type": "Person", "name": "A A Eremenko", "url": "https://questionsmedicales.fr/author/A%20A%20Eremenko", "affiliation": { "@type": "Organization", "name": "Petrovsky Russian Research Center of Surgery, Moscow, Russia." } }, { "@type": "Person", "name": "Shereen A Boltia", "url": "https://questionsmedicales.fr/author/Shereen%20A%20Boltia", "affiliation": { "@type": "Organization", "name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt." } }, { "@type": "Person", "name": "Aya T Soudi", "url": "https://questionsmedicales.fr/author/Aya%20T%20Soudi", "affiliation": { "@type": "Organization", "name": "Cairo University, Faculty of Pharmacy, Analytical Chemistry Department, Kasr El-Aini St, Cairo 11562, Egypt." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The sensitivity and specificity of COVID-19 rapid anti-gene test in comparison to RT-PCR test as a gold standard test.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36725342", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jcla.24844" } }, { "@type": "ScholarlyArticle", "name": "On determining the sensitivity and specificity of a new diagnostic test through comparing its results against a non-gold-standard test.", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36627979", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.11613/BM.2023.010101" } }, { "@type": "ScholarlyArticle", "name": "Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis.", "datePublished": "2023-06-21", "url": "https://questionsmedicales.fr/article/37345346", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/mus.27923" } }, { "@type": "ScholarlyArticle", "name": "Sensitivity and specificity of monocyte distribution width (MDW) in detecting patients with infection and sepsis in patients on sepsis pathway in the emergency department.", "datePublished": "2022-11-18", "url": "https://questionsmedicales.fr/article/36399260", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s15010-022-01956-y" } }, { "@type": "ScholarlyArticle", "name": "Large-scale pathogenicity prediction analysis of cancer-associated kinase mutations reveals variability in sensitivity and specificity of computational methods.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37409618", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cam4.6324" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Composés benzhydryliques", "item": "https://questionsmedicales.fr/mesh/D001559" }, { "@type": "ListItem", "position": 8, "name": "Orphénadrine", "item": "https://questionsmedicales.fr/mesh/D009966" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Orphénadrine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Orphénadrine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Orphénadrine", "description": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?\nQuels tests sont utiles avant de prescrire l'orphénadrine ?\nL'orphénadrine est-elle indiquée pour tous les types de douleurs ?\nQuels signes cliniques justifient l'utilisation de l'orphénadrine ?\nL'orphénadrine est-elle utilisée en cas de fibromyalgie ?", "url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Sensitivity+and+Specificity&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Orphénadrine", "description": "Quels sont les effets secondaires courants de l'orphénadrine ?\nL'orphénadrine peut-elle provoquer des réactions allergiques ?\nQuels symptômes indiquent une surdose d'orphénadrine ?\nL'orphénadrine peut-elle causer des troubles de la vision ?\nQuels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?", "url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Sensitivity+and+Specificity&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Orphénadrine", "description": "Comment prévenir les douleurs nécessitant l'orphénadrine ?\nL'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?\nLe stress peut-il aggraver les douleurs musculaires ?\nDes étirements réguliers peuvent-ils prévenir les douleurs ?\nLe repos est-il important pour prévenir les douleurs musculaires ?", "url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Sensitivity+and+Specificity&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Orphénadrine", "description": "Comment l'orphénadrine est-elle administrée ?\nQuelle est la posologie standard de l'orphénadrine ?\nL'orphénadrine peut-elle être combinée avec d'autres médicaments ?\nQuels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?\nL'orphénadrine est-elle efficace contre les douleurs chroniques ?", "url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Sensitivity+and+Specificity&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Orphénadrine", "description": "Quelles complications peuvent survenir avec l'orphénadrine ?\nL'orphénadrine peut-elle entraîner une dépendance ?\nQuels signes indiquent une complication grave de l'orphénadrine ?\nComment gérer les complications liées à l'orphénadrine ?\nL'orphénadrine peut-elle affecter la fonction hépatique ?", "url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Sensitivity+and+Specificity&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Orphénadrine", "description": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?\nLes personnes âgées sont-elles plus sensibles à l'orphénadrine ?\nL'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?\nLes antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?\nLes femmes enceintes peuvent-elles prendre de l'orphénadrine ?", "url": "https://questionsmedicales.fr/mesh/D009966?mesh_terms=Sensitivity+and+Specificity&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une douleur musculaire nécessitant l'orphénadrine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et l'historique des symptômes." } }, { "@type": "Question", "name": "Quels tests sont utiles avant de prescrire l'orphénadrine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'imagerie et des analyses sanguines peuvent être réalisés pour évaluer l'état musculaire." } }, { "@type": "Question", "name": "L'orphénadrine est-elle indiquée pour tous les types de douleurs ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle est principalement indiquée pour les douleurs musculaires et les spasmes." } }, { "@type": "Question", "name": "Quels signes cliniques justifient l'utilisation de l'orphénadrine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des douleurs aiguës, des spasmes et une raideur musculaire." } }, { "@type": "Question", "name": "L'orphénadrine est-elle utilisée en cas de fibromyalgie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être utilisée pour soulager certains symptômes de la fibromyalgie." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants de l'orphénadrine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent la sécheresse buccale, la somnolence et des vertiges." } }, { "@type": "Question", "name": "L'orphénadrine peut-elle provoquer des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions allergiques comme des éruptions cutanées peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose d'orphénadrine ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent confusion, hallucinations et tachycardie." } }, { "@type": "Question", "name": "L'orphénadrine peut-elle causer des troubles de la vision ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner une vision floue ou des troubles visuels temporaires." } }, { "@type": "Question", "name": "Quels symptômes nécessitent l'arrêt immédiat de l'orphénadrine ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des palpitations, des éruptions cutanées ou des difficultés respiratoires." } }, { "@type": "Question", "name": "Comment prévenir les douleurs nécessitant l'orphénadrine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des exercices réguliers, une bonne posture et des pauses fréquentes peuvent aider." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention des douleurs musculaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut contribuer à la santé musculaire." } }, { "@type": "Question", "name": "Le stress peut-il aggraver les douleurs musculaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les tensions musculaires et les douleurs." } }, { "@type": "Question", "name": "Des étirements réguliers peuvent-ils prévenir les douleurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les étirements réguliers aident à maintenir la flexibilité et à prévenir les douleurs." } }, { "@type": "Question", "name": "Le repos est-il important pour prévenir les douleurs musculaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un repos adéquat est essentiel pour la récupération musculaire." } }, { "@type": "Question", "name": "Comment l'orphénadrine est-elle administrée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle est généralement administrée par voie orale sous forme de comprimés." } }, { "@type": "Question", "name": "Quelle est la posologie standard de l'orphénadrine ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La posologie standard est de 100 mg deux fois par jour, selon les besoins." } }, { "@type": "Question", "name": "L'orphénadrine peut-elle être combinée avec d'autres médicaments ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, mais il est important de consulter un médecin pour éviter les interactions." } }, { "@type": "Question", "name": "Quels sont les avantages de l'orphénadrine par rapport à d'autres traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle offre un soulagement rapide des spasmes musculaires et des douleurs." } }, { "@type": "Question", "name": "L'orphénadrine est-elle efficace contre les douleurs chroniques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être efficace pour certaines douleurs chroniques, mais pas pour toutes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'orphénadrine ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles cardiaques ou des problèmes neurologiques peuvent survenir." } }, { "@type": "Question", "name": "L'orphénadrine peut-elle entraîner une dépendance ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle a un faible potentiel de dépendance, mais une utilisation prolongée doit être surveillée." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave de l'orphénadrine ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs thoraciques, des évanouissements ou des convulsions." } }, { "@type": "Question", "name": "Comment gérer les complications liées à l'orphénadrine ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Il est crucial de consulter un médecin pour ajuster le traitement ou changer de médicament." } }, { "@type": "Question", "name": "L'orphénadrine peut-elle affecter la fonction hépatique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests de la fonction hépatique peuvent être nécessaires en cas d'utilisation prolongée." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'effets secondaires de l'orphénadrine ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies préexistantes et l'utilisation d'autres médicaments augmentent le risque." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus sensibles à l'orphénadrine ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de l'orphénadrine." } }, { "@type": "Question", "name": "L'usage d'alcool influence-t-il l'efficacité de l'orphénadrine ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'alcool peut augmenter les effets sédatifs de l'orphénadrine." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils l'utilisation de l'orphénadrine ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies cardiaques ou neurologiques peuvent limiter son utilisation." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles prendre de l'orphénadrine ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'orphénadrine doit être utilisée avec prudence chez les femmes enceintes, après avis médical." } } ] } ] }

Sources (10000 au total)

The sensitivity and specificity of COVID-19 rapid anti-gene test in comparison to RT-PCR test as a gold standard test.

Coronavirus disease 2019 (COVID-19) is a modern infectious disease, first identified in December 2019 in Wuhan, China. The etiology is via severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),... This is a cohort hospital-based study done during the period of July to September 2020. Both rapid anti-gene test kit (SARS-CoV-2) and RT-qPCR were used for the detection of COVID-19 in suspected case... A total of 148 cases were tested using both the RT-qPCR and rapid test. Twenty-nine (19.6%) of these cases had positive results for RT-qPCR and 119 (80.4%) were negative, whereas 52 (35.1%) patients w... We cannot consider rapid anti-gene test alone as a diagnostic method for COVID-19. We should also conduct RT-PCR test and other investigations like imaging CT scan of chest to confirm the diagnosis. T...

Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis.

Given the widespread use of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) to measure disease progression in ALS and recent reports demonstrating its poor sensitivity, we... Paired ALSFRS-R and validated Speech Intelligibility Test (SIT) data from individuals with ALS were analyzed. Trained raters completed duplicate, independent, and blinded ratings of audio recordings t... A total of 250 paired SIT and ALSFRS-R data points were analyzed. Dysarthria was confirmed in 72.4% (n = 181). Dysarthric speakers demonstrated lower ALSFRS-R bulbar subscale (8.9 vs. 11.2) and speech... The ALSFRS-R bulbar and speech item subscale scores may be useful, inexpensive, and quick tools for monitoring dysarthria status in ALS....

Sensitivity and specificity of monocyte distribution width (MDW) in detecting patients with infection and sepsis in patients on sepsis pathway in the emergency department.

Monocyte distribution width (MDW) is a biomarker for the early identification of sepsis. We assessed its accuracy in patients presenting with suspected sepsis in the emergency department (ED).... This was a single gate, single centre study in consecutive adults (≥ 18 years) admitted to the ED with suspected sepsis and clinical history compatible with infection, between 01 January and 31 Decemb... The overall median MDW was 22.0 (IQR 19.3, 25.6). Using Sepsis-3 (qSOFA) to define sepsis, the Area Under Curve (AUC) for a receiver operator characteristic (ROC) relationship was 0.59 (95% CI 0.56, 0... In this population of ED admissions with a strong clinical suspicion of sepsis, MDW had a performance to identify sepsis comparable to that of other commonly used biomarkers. In this setting, MDW coul...

Large-scale pathogenicity prediction analysis of cancer-associated kinase mutations reveals variability in sensitivity and specificity of computational methods.

Mutations in kinases are the most frequent genetic alterations in cancer; however, experimental evidence establishing their cancerous nature is available only for a small fraction of these mutants.... Predicition analysis of kinome mutations is the primary aim of this study. Further objective is to compare the performance of various softwares in pathogenicity prediction of kinase mutations.... We employed a set of computational tools to predict the pathogenicity of over forty-two thousand mutations and deposited the kinase-wise data in Mendeley database (Estimated Pathogenicity of Kinase Mu... Mutations are more likely to be drivers when being present in the kinase domain (vs. non-kinase domain) and belonging to hotspot residues (vs. non-hotspot residues). We identified that, while predicti... The study provides a large dataset of kinase mutations along with their predicted pathogenicity that can be used as a training set for future studies. Furthermore, a comparative sensitivity and select... Primary-structure-based in silico tools identified more cancerous/deleterious mutations in the kinase domains and at the hot spot residues while having higher sensitivity than specificity in detecting...

A sensitive and specific nano-vehicle based on self-amplified dual-input synthetic gene circuit for intracellular imaging and treatment.

Synthetic genetic circuits (SGCs) that sense multiple biomarkers and respond intelligently provide a powerful tool for intracellular biosensing. The SGC is usually loaded into the nanoscale liposomes ...

FEN1-aided recombinase polymerase amplification (FARPA) for one-pot and multiplex detection of nucleic acids with an ultra-high specificity and sensitivity.

Recombinase polymerase amplification (RPA) running at 37-42 °C is fast, efficient and less-implemented; however, the existing technologies of nucleic acid testing based on RPA have some limitations in...

A Novel Scoring System for MYB RNA In Situ Hybridization Displays High Sensitivity and Specificity for Adenoid Cystic Carcinoma in a Clinical Setting.

MYB RNA in situ hybridization (ISH) has emerged as a reliable and accessible marker to support adenoid cystic carcinoma (ACC) diagnosis, though still not well studied. Here, we report our results in a... 79 cases (23 retrospective and 56 prospective) underwent MYB RNA ISH testing (44 ACC and 35 non-ACC). MYB RNA ISH results were initially interpreted based on previously established (original) scoring ... An abluminal pattern was characteristic and exclusive to ACC. All i-scores, % LS, and percent positive were significantly higher in ACC. Original scoring criteria yielded a 95.5% sensitivity (Sn), 68.... MYB RNA ISH has a higher Sn than MYB::NFIB FISH while retaining high Sp. Our model provides improvements to specificity compared to original scoring criteria and highlight the importance of abluminal ...

Estimating sensitivity and specificity of diagnostic tests using latent class models that account for conditional dependence between tests: a simulation study.

Latent class models are increasingly used to estimate the sensitivity and specificity of diagnostic tests in the absence of a gold standard, and are commonly fitted using Bayesian methods. These model... A simulation study and a reanalysis of a published case study are used to highlight the impact of the conditional dependence structure chosen on estimates of sensitivity and specificity. We describe a... The findings highlight that assuming conditional independence between tests within a latent class, where conditional dependence exists, results in biased estimates of sensitivity and specificity and p... We have illustrated that misspecification of the conditional dependence structure leads to biased estimates of sensitivity and specificity when there is a correlation between tests. Due to the minimal...